Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treprostinil and Riociguat in Advanced PAH
NCT04062565Phase 3Recruiting
- Sponsor
- University of Arizona
- Start
- Mar 2019
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of riociguat in pulmonary arterial hypertension (PAH), sponsored by University of Arizona. Started Mar 2019; status: recruiting.
02
Drugs
riociguat
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT04062565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04062565.